Skip to main content
. 2020 Feb 13;14(4):779–794. doi: 10.1002/1878-0261.12640

Table 1.

IC50 in PKC412‐ and sorafenib‐sensitive and PKC412‐ and sorafenib‐resistant cell lines. 1 × 104 cells were cultured with increasing concentration of PKC412 (5–1000 nm). Cell viability was measured after addition of MTS. The respective IC50 was calculated by nonlinear regression analysis (log inhibitor vs. response). Mean IC50 (n = 6; 2 experiments) with standard error (SE) as LogIC50 is depicted

PKC412 Sorafenib
Cell line IC50 in nmol/l SEM as LogIC50 Cell line IC50 in nmol/l SEM as LogIC50
MOLM13 32.17 0.05 MOLM13 4.66 0.05
PKC C5 105.0 0.03 Sora C4 267 0.04
PKC E9 136.2 0.03 Sora D3 291 0.12
PKC F6 147.0 0.07 Sora D11 63.9 0.16
PKC F9 156.1 0.02 Sora E7 264 0.15
PKC G7 170.5 0.08 Sora G8 68.1 0.10